<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="(CABB), University of Agriculture, [2], grid.413016.10000 0004 0607 1563Center for" exact="Advanced" post="Studies in Agriculture and Food Security (CAS-AFS), University of"/>
 <result pre="in a credit line to the data. Abstract Background The" exact="Severe" post="acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) outbreak originating in"/>
 <result pre="a credit line to the data. Abstract Background The Severe" exact="acute" post="respiratory syndrome-related coronavirus 2 (SARS-CoV-2) outbreak originating in Wuhan,"/>
 <result pre="credit line to the data. Abstract Background The Severe acute" exact="respiratory" post="syndrome-related coronavirus 2 (SARS-CoV-2) outbreak originating in Wuhan, China,"/>
 <result pre="continents. Hitherto, no antiviral drug is available to combat this" exact="viral" post="outbreak. Methods Keeping in mind the urgency of the"/>
 <result pre="In the current study, RNA-dependent RNA polymerase (RdRp), which regulates" exact="viral" post="replication, is proposed as a potential therapeutic target to"/>
 <result pre="replication, is proposed as a potential therapeutic target to inhibit" exact="viral infection." post="Results Evolutionary studies of whole-genome sequences of SARS-CoV-2 represent"/>
 <result pre="potential therapeutic option for inhibition of coronavirus RdRp, and thus" exact="viral" post="replication. Target-based virtual screening and molecular docking results show"/>
 <result pre="SARS-CoV-2 Phylogenetic tree Homology modeling Molecular Docking Active site Background" exact="Severe" post="acute respiratory syndrome coronavirus (SARS-CoV) is a positive-sense single-stranded"/>
 <result pre="Phylogenetic tree Homology modeling Molecular Docking Active site Background Severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) is a positive-sense single-stranded RNA"/>
 <result pre="tree Homology modeling Molecular Docking Active site Background Severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) is a positive-sense single-stranded RNA virus"/>
 <result pre="Homology modeling Molecular Docking Active site Background Severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) is a positive-sense single-stranded RNA virus from"/>
 <result pre="SARS-CoV-2 first infected humans from a bat host during interspecies" exact="viral" post="transmission. In support, it has been reported in China"/>
 <result pre="reported in China and other countries that bats are the" exact="primary" post="reservoirs of SARS-CoV-2 [6â€&quot;8]. Coronaviruses are a large family"/>
 <result pre="the common cold to severe diseases such as Middle East" exact="respiratory" post="syndrome (MERS) and severe acute respiratory syndrome (SARS). SARS-CoV-2"/>
 <result pre="common cold to severe diseases such as Middle East respiratory" exact="syndrome" post="(MERS) and severe acute respiratory syndrome (SARS). SARS-CoV-2 is"/>
 <result pre="diseases such as Middle East respiratory syndrome (MERS) and severe" exact="acute" post="respiratory syndrome (SARS). SARS-CoV-2 is one of the seven"/>
 <result pre="such as Middle East respiratory syndrome (MERS) and severe acute" exact="respiratory" post="syndrome (SARS). SARS-CoV-2 is one of the seven coronaviruses"/>
 <result pre="as Middle East respiratory syndrome (MERS) and severe acute respiratory" exact="syndrome" post="(SARS). SARS-CoV-2 is one of the seven coronaviruses known"/>
 <result pre="SARS-CoV-2 is one of the seven coronaviruses known to cause" exact="infection" post="in Homo sapiens, which also includes: 229E (HCoV-229E), NL63"/>
 <result pre="been confirmed that SARS-CoV-2 can spread with human-to-human transmission via" exact="respiratory" post="droplets (e.g. through coughing or sneezing) or even by"/>
 <result pre="thereby resulting in amino acid shifts which ultimately modify functional" exact="viral" post="protein(s). This could be the case for SARS-CoV-2, in"/>
 <result pre="protein(s). This could be the case for SARS-CoV-2, in that" exact="viral" post="proteins are actively acquiring mutations due to SNPs and"/>
 <result pre="(nsp5) and RdRP (nsp12) which plays an important role in" exact="viral" post="replication, whereas helicase (nsp13) has been recognized to unwind"/>
 <result pre="for retrovirusesâ€&quot;require an RdRp for replication and transcription of the" exact="viral" post="genome, making it essential for their survival [29, 30]."/>
 <result pre="antiviral drugs [32â€&quot;39]. RdRp plays a crucial role in the" exact="viral" post="life cycle, and as the active site of the"/>
 <result pre="conserved and accessible region, targeting this region for inhibition of" exact="viral" post="replication may be an effective therapeutic approach. Scientists worldwide"/>
 <result pre="Galidesivir, Remdesivir, etc.â€&quot;are in clinical trials for different viruses (e.g." exact="Hepatitis" post="C, Zika virus, Dengue and SARS-CoV-2) on the basis"/>
 <result pre="clinical trials for different viruses (e.g. Hepatitis C, Zika virus," exact="Dengue" post="and SARS-CoV-2) on the basis of anti-RdRp activity [44â€&quot;51]."/>
 <result pre="Galidesivir, similar to structurally similar antiviral compounds, to inhibit the" exact="viral" post="replication protein RdRp. An evolutionary-based study was performed to"/>
 <result pre="that can further be used for preclinical trials to halt" exact="viral" post="replication after prior testing. Our results are promising and"/>
 <result pre="Materials and methods Sequence retrieval, alignment and evolutionary relationship of" exact="viral" post="species The SARS-CoV-2 whole-genome sequence was retrieved from NCBI"/>
 <result pre="for Biotechnology Information) under Accession # NC_045512.2. In addition, a" exact="total" post="of 94 whole-genome viral sequences belonging only to class"/>
 <result pre="Accession # NC_045512.2. In addition, a total of 94 whole-genome" exact="viral" post="sequences belonging only to class Nidovirales, order Coronaviradae, family"/>
 <result pre="and maximum likelihood estimation (MLE) tree was constructed against all" exact="viral" post="genome sequences for tracing the evolutionary record with SARS-CoV-2"/>
 <result pre="evolutionary record with SARS-CoV-2 using a bootstrap value of 1000." exact="Protein" post="sequence retrieval and estimation of physicochemical properties Sequence of"/>
 <result pre="analyzed through ProtParam tool of ExPASy for evaluation of the" exact="primary" post="structure of RdRp protein. Homology modeling and protein phylogenetic"/>
 <result pre="to infer its similarity with other RdRp protein sequences; 94" exact="total" post="sequences were selected that exhibitedâ€‰&amp;gt;â€‰90% similarity with our input"/>
 <result pre="optimal docked compounds were selected based on higher S-score and" exact="lower" post="RMSD with a reference inhibitor (PubChem CID: 10445549). Docking"/>
 <result pre="agents on humans. Results Evolutionary relationship of SARS-CoV-2 with other" exact="viral" post="isolates A phylogenetic tree infers relative evolutionary distance with"/>
 <result pre="respect to other species. Tracing evolutionary history among all possible" exact="viral" post="relatives using a genome sequence of interest can elucidate"/>
 <result pre="study, we identified interspecies divergence among all the 94 validated" exact="viral" post="genomic sequences belonging to the family Coronavirinae retrieved from"/>
 <result pre="also included most of the beta-CoV members, with only two" exact="viral" post="species clustered in a separate clade belong to alpha-CoV."/>
 <result pre="structure depends upon three-dimensional conformation based on amino acid sequence." exact="Protein" post="sequences were assembled based on their physicochemical properties. ProtParam"/>
 <result pre="is capable of making hydrogen bonds, categorizing it as a" exact="stable" post="protein (TableÂ 1). TableÂ 1 Physicochemical properties of RdRP"/>
 <result pre="Pro (P) 30 3.20 Formula C4792H7265N1259O1401S54 Ser (S) 53 5.70" exact="Total" post="number of atoms 14,771 Thr (T) 61 6.50 Trp"/>
 <result pre="the NCBI database for evaluating its phylogenetic relationship with other" exact="viral" post="RdRp proteins. An MLE tree constructed for all validated"/>
 <result pre="into three clades: I, II, and III. Most of the" exact="viral" post="RdRps in clade I belong to beta-CoV; the same"/>
 <result pre="selected for ligand-based virtual screening from the PubChem database. A" exact="total" post="of 1061 compounds were retrieved and Pfizerâ€™s rule of"/>
 <result pre="are presented in Figs.Â 6 and 7. We suggest two" exact="non-toxic" post="drug-like compounds predicted to bind ASP761, ASP760, SER814 and"/>
 <result pre="compounds. Ames toxicity testing results revealed that the compounds were" exact="non-toxic" post="and non-carcinogenic (TableÂ 3, Fig.Â 8). CID123624208 and CID11687749"/>
 <result pre="sequences from alpha-, beta-, and gamma coronaviruses. Most of the" exact="viral" post="species examined showed resemblance to each other and clustered"/>
 <result pre="the RdRp protein sequence was searched for similarity with other" exact="viral" post="RdRps. Our results demonstrated that all the SARS-CoV-2 RdRp"/>
 <result pre="more research is needed to explore the differentiation between these" exact="viral" post="RdRps. Docking simulations of results of our study are"/>
 <result pre="as potential inhibitors against the RdRp of SARS-CoV-2. Numerous other" exact="viral" post="inhibitors have also been reported which are in clinical"/>
 <result pre="theÂ objective of virologists in treating the patients of new" exact="viral infection" post="caused by SARS-CoV-2. The choice of FDA approved drugs"/>
 <result pre="objective of virologists in treating the patients of new viral" exact="infection" post="caused by SARS-CoV-2. The choice of FDA approved drugs"/>
 <result pre="the most frequently used and suggested potential target to inhibit" exact="viral" post="replication. In this study, we tested some important anti"/>
 <result pre="currently in clinical trials or in the market to stop" exact="viral infection" post="on an emergency basis. However, Galidesivir and its drug-like"/>
 <result pre="in clinical trials or in the market to stop viral" exact="infection" post="on an emergency basis. However, Galidesivir and its drug-like"/>
 <result pre="have shown an effective attachment to the priming site of" exact="viral" post="RdRp, which could lead to replication failure. Moreover, for"/>
 <result pre="Origin and Accession # of recently emerged SARS coronaviruses and" exact="viral" post="RdRps. Abbreviations AA amino acids BBB bloodâ€&quot;brain barrier DOPE"/>
 <result pre="ICTV International Committee on Taxonomy of Viruses MERS middle east" exact="respiratory" post="syndrome MLE maximum likelihood estimation MOE molecular operating environment"/>
 <result pre="International Committee on Taxonomy of Viruses MERS middle east respiratory" exact="syndrome" post="MLE maximum likelihood estimation MOE molecular operating environment MW"/>
 <result pre="RMSD root-mean-square deviation ROCT renal organic cation transporter SARS severe" exact="acute" post="respiratory syndrome WHO World Health Organization Publisher's Note Springer"/>
 <result pre="root-mean-square deviation ROCT renal organic cation transporter SARS severe acute" exact="respiratory" post="syndrome WHO World Health Organization Publisher's Note Springer Nature"/>
 <result pre="deviation ROCT renal organic cation transporter SARS severe acute respiratory" exact="syndrome" post="WHO World Health Organization Publisher's Note Springer Nature remains"/>
 <result pre="2011Emerg Infect Dis20131998923739658 2.WongSLauSWooPYuenKYBats as a continuing source of emerging" exact="infections" post="in humansRev Med Virol200717679117042030 3.HuBGeXWangLFShiZBat origin of human coronavirusesVirol"/>
 <result pre="J.20151222126689940 4.LiWShiZYuMRenWSmithCEpsteinJHWangHCrameriGHuZZhangHZhangJBats are natural reservoirs of SARS-like coronavirusesScience200531067667916195424 5.WHO. Coronavirus" exact="Disease" post="2019 (COVID-19) Situation Report-81. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200410-sitrep-81-covid-19.pdf?sfvrsn=ca96eb84_2. Accessed 15 Apr"/>
 <result pre="Situation Report-81. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200410-sitrep-81-covid-19.pdf?sfvrsn=ca96eb84_2. Accessed 15 Apr 2020. 6.LauSKLiKSHuangYShekCTTseHWangMChoiGKXuHLamCSGuoRChanKHEcoepidemiology and" exact="complete" post="genome comparison of different strains of severe acute respiratory"/>
 <result pre="6.LauSKLiKSHuangYShekCTTseHWangMChoiGKXuHLamCSGuoRChanKHEcoepidemiology and complete genome comparison of different strains of severe" exact="acute" post="respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats"/>
 <result pre="and complete genome comparison of different strains of severe acute" exact="respiratory" post="syndrome-related Rhinolophus bat coronavirus in China reveal bats as"/>
 <result pre="in China reveal bats as a reservoir for acute, self-limiting" exact="infection" post="that allows recombination eventsJ Virol2010842808281920071579 7.AhlquistPNoueiryAOLeeWMKushnerDBDyeBTHost factors in positive-strand"/>
 <result pre="10.YinYWunderinkRGMERS, SARS and other coronaviruses as causes of pneumoniaRespirology20182313013729052924 11.ChangLYanYWangLCoronavirus" exact="disease" post="2019: coronaviruses and blood safetyTransfus Med Rev.2020342758010.1016/j.tmrv.2020.02.00332107119 12.AshourHMElkhatibWFRahmanMElshabrawyHAInsights into"/>
 <result pre="virusesCell Res20203018919032071427 14.PengXXuXLiYet al.Transmission routes of 2019-nCoV and controls in" exact="dental" post="practiceInt J Oral Sci202012910.1038/s41368-020-0075-932127517 15.LuCWLiuXFJiaZF2019-nCoV transmission through the ocular"/>
 <result pre="in dental practiceInt J Oral Sci202012910.1038/s41368-020-0075-932127517 15.LuCWLiuXFJiaZF2019-nCoV transmission through the" exact="ocular" post="surface must not be ignoredLancet.2020395e3932035510 16.Kieny MP. After Ebola,"/>
 <result pre="17.Boulos MN, Geraghty EM. Geographical tracking and mapping of coronavirus" exact="disease" post="COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and"/>
 <result pre="Geraghty EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events"/>
 <result pre="EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around"/>
 <result pre="Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) epidemic and associated events around the"/>
 <result pre="F, Liu J, Yip CC, Poon RW, Tsoi HW. A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="Yip CC, Poon RW, Tsoi HW. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="Y, Akhmetzhanov AR, Nishiura H. Epidemiological identification of a novel" exact="infectious disease" post="in real time: Analysis of the atypical pneumonia outbreak"/>
 <result pre="Akhmetzhanov AR, Nishiura H. Epidemiological identification of a novel infectious" exact="disease" post="in real time: Analysis of the atypical pneumonia outbreak"/>
 <result pre="a novel infectious disease in real time: Analysis of the" exact="atypical pneumonia" post="outbreak in Wuhan, China, 2019-20. medRxiv. 2020. 21.Wang M,"/>
 <result pre="novel infectious disease in real time: Analysis of the atypical" exact="pneumonia" post="outbreak in Wuhan, China, 2019-20. medRxiv. 2020. 21.Wang M,"/>
 <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Military Medical Research.20207432029004 23.KruseRLTherapeutic strategies in an outbreak"/>
 <result pre="27.WooPCHuangYLauSKYuenKYCoronavirus genomics and bioinformatics analysisViruses.201021804182021994708 28.JiaZYanLRenZWuLWangJGuoJZhengLMingZZhangLLouZRaoZDelicate structural coordination of the" exact="Severe" post="Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysisNucleic Acids"/>
 <result pre="genomics and bioinformatics analysisViruses.201021804182021994708 28.JiaZYanLRenZWuLWangJGuoJZhengLMingZZhangLLouZRaoZDelicate structural coordination of the Severe" exact="Acute" post="Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res2019476538655031131400"/>
 <result pre="and bioinformatics analysisViruses.201021804182021994708 28.JiaZYanLRenZWuLWangJGuoJZhengLMingZZhangLLouZRaoZDelicate structural coordination of the Severe Acute" exact="Respiratory" post="Syndrome coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res2019476538655031131400 29.Chatterjee"/>
 <result pre="bioinformatics analysisViruses.201021804182021994708 28.JiaZYanLRenZWuLWangJGuoJZhengLMingZZhangLLouZRaoZDelicate structural coordination of the Severe Acute Respiratory" exact="Syndrome" post="coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res2019476538655031131400 29.Chatterjee S."/>
 <result pre="of poliovirusStructure.19975110911229309225 34.AgoHAdachiTYoshidaAYamamotoMHabukaNYatsunamiKMiyanoMCrystal structure of the RNA-dependent RNA polymerase of" exact="hepatitis C" post="virusStructure.199971417142610574802 35.BressanelliSTomeiLRousselAIncittiIVitaleRLMathieuMDe FrancescoRReyFACrystal structure of the RNA-dependent RNA polymerase"/>
 <result pre="virusStructure.199971417142610574802 35.BressanelliSTomeiLRousselAIncittiIVitaleRLMathieuMDe FrancescoRReyFACrystal structure of the RNA-dependent RNA polymerase of" exact="hepatitis C" post="virusProc Natl Acad Sci199996130341303910557268 36.LesburgCACableMBFerrariEHongZMannarinoAFWeberPCCrystal structure of the RNA-dependent"/>
 <result pre="Acad Sci199996130341303910557268 36.LesburgCACableMBFerrariEHongZMannarinoAFWeberPCCrystal structure of the RNA-dependent RNA polymerase from" exact="hepatitis C" post="virus reveals a fully encircled active siteNat Struct Biol1999693794310504728"/>
 <result pre="fully encircled active siteNat Struct Biol1999693794310504728 37.KinsellaEMartinSGGrollaACzubMFeldmannHFlickRSequence determination of the" exact="Crimean-Congo hemorrhagic fever" post="virus L segmentVirology2004321232815033561 38.LiangBLiZJenniSRahmehAAMorinBMGrantTGrigorieffNHarrisonSCWhelanSPStructure of the L protein of"/>
 <result pre="virus L segmentVirology2004321232815033561 38.LiangBLiZJenniSRahmehAAMorinBMGrantTGrigorieffNHarrisonSCWhelanSPStructure of the L protein of vesicular" exact="stomatitis" post="virus from electron cryomicroscopyCell201516231432726144317 39.GerlachPMaletHCusackSRegueraJStructural insights into bunyavirus replication"/>
 <result pre="Discov.2020146 42.YuWCHuiDSCChan-YeungMAntiviral agents and corticosteroids in the treatment of severe" exact="acute" post="respiratory syndrome (SARS)Thorax20045964364515282381 43.ElfikyAAAnti-HCV, nucleotide inhibitors, repurposing against COVID-19Life"/>
 <result pre="42.YuWCHuiDSCChan-YeungMAntiviral agents and corticosteroids in the treatment of severe acute" exact="respiratory" post="syndrome (SARS)Thorax20045964364515282381 43.ElfikyAAAnti-HCV, nucleotide inhibitors, repurposing against COVID-19Life Sci202024811747732119961"/>
 <result pre="agents and corticosteroids in the treatment of severe acute respiratory" exact="syndrome" post="(SARS)Thorax20045964364515282381 43.ElfikyAAAnti-HCV, nucleotide inhibitors, repurposing against COVID-19Life Sci202024811747732119961 44.ElfikyAAMahdySMElshemeyWMQuantitative"/>
 <result pre="C virus drugs against human corona virusesJ Med Virol2017891040104727864902 45.ElfikyAAZika" exact="viral" post="polymerase inhibition using anti-HCV drugs both in market and"/>
 <result pre="at 2.8 Ã… resolutionJ Mol Biol.1998284109511119837729 64.Jacobo-MolinaADingJNanniRGClarkADLuXTantilloCWilliamsRLKamerGFerrisALClarkPCrystal structure of human" exact="immunodeficiency" post="virus type 1 reverse transcriptase complexed with double-stranded DNA"/>
 <result pre="Ã… resolutionJ Mol Biol.1998284109511119837729 64.Jacobo-MolinaADingJNanniRGClarkADLuXTantilloCWilliamsRLKamerGFerrisALClarkPCrystal structure of human immunodeficiency virus" exact="type 1" post="reverse transcriptase complexed with double-stranded DNA at 3.0 A"/>
</results>
